Vemurafenib‐induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

Saved in:
Bibliographic Details
Published inInternational journal of dermatology Vol. 59; no. 5; pp. e139 - e141
Main Authors Olteanu, Cristina, Scope, Alon, Steinberg‐Silman, Yael, Ziv, Michael, Shear, Neil H., Dodiuk‐Gad, Roni P., Markel, Gal
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2020
Subjects
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Azetidines - administration & dosage
Biopsy
Drug Hypersensitivity Syndrome - diagnosis
Drug Hypersensitivity Syndrome - drug therapy
Drug Hypersensitivity Syndrome - immunology
Female
Glucocorticoids - therapeutic use
Humans
Immunology
Lung - diagnostic imaging
Lung - immunology
Lung Neoplasms - diagnosis
Lung Neoplasms - drug therapy
Lung Neoplasms - immunology
Lung Neoplasms - secondary
Melanoma
Melanoma - diagnosis
Melanoma - drug therapy
Melanoma - immunology
Melanoma - secondary
Middle Aged
Piperidines - administration & dosage
Positron Emission Tomography Computed Tomography
Skin - diagnostic imaging
Skin - drug effects
Skin - immunology
Skin - pathology
Skin Neoplasms - diagnosis
Skin Neoplasms - drug therapy
Skin Neoplasms - immunology
Skin Neoplasms - pathology
Treatment Outcome
Vemurafenib - administration & dosage
Vemurafenib - adverse effects
Online AccessGet full text

Cover

More Information
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.14852